twt-101: cfi-402411 alone or with pembrolizumab in patients with advanced tumors
Published 2 years ago • 248 plays • Length 2:07Download video MP4
Download video MP3
Similar videos
-
1:52
safety of bca101, an egfr/tgfβ inhibitor, with pembrolizumab in hnscc
-
0:39
phase i/ii study of adapt-001 plus an ici for patients with immune refractory cancers
-
50:08
clinical trials 101
-
4:55
mutation testing
-
6:27
immunotherapy in msi-high pancreatic tumors
-
7:29
first-line treatment recommendations based on tmb
-
1:24
dr. falchook on ktn3379 in advanced tumors on ktn3379 in advanced tumors
-
1:15
dr. cohen on mtor inhibition in head and neck cancer
-
1:10
understanding of thyroid tumor biology
-
53:59
immunotherapy 101
-
![analyzing hundreds of markers in a single tumor section [webinar]](https://i.ytimg.com/vi/RAb-SJdrnos/mqdefault.jpg)
33:57
analyzing hundreds of markers in a single tumor section [webinar]
-
1:01:58
clinical trials 101
-
9:02
pd1/ ctla4 : upfront or sequentially?
-
3:48
results from the first-in-human trial of tg-1801 in patients with b-cell lymphoma
-
0:33
tall cell variant of papillary carcinoma. other rare tumors - case 1
-
3:08
engineering an inhibitor-resistant human csf1r variant for microglia replacement
-
10:33
heart failure treatment - ccm: addressing unmet clinical needs in heart failure
-
58:38
2021 oneoncology | advancing precision oncology in the community | molecular tumor board
-
19:37
early breast cancer: the ebctcg meta-analyses